bioRxivBioengineeringPreprint
Valve endothelial monolayer fissuring via RhoA activity induces 3D calcific aortic valve lesion emergence as revealed by a longitudinal live-imaging platform
Katherine DriscolliD, Santosh BalakrishnaniD, G. Janani, Hrishika Gogineni, Alessandra Good, Andrea Huang, Nichaluk LeartprapuniD, Steven G. AdieiD, Jonathan Talbot ButcheriD
Abstract
Calcific aortic valve disease (CAVD) is a degenerative disease with wide prevalence in the aging population and a low survival rate after onset of symptoms, yet there are no effective pharmacological treatments. Many patients present to the clinic with symptoms at end-stages of CAVD, when the disease may be irreversible. The ability to identify and live-trace calcific lesion emergence in-vivo would allow for the identification of disease biomarkers and discovery of therapeutic targets at earlier, more treatable stages. In this work, we establish a new multimodal in-vitro CAVD platform consisting of lineage traced-VEC and VIC cells in a 3D model combined with live optical coherence and fluorescence microscopy to unravel VEC, VIC, and matrix transitional events during calcific lesion formation. We discover that fissuring of the endothelial monolayer combined with the formation of dense aggregates in adjacent regions is a key biomarker of the onset of lesion formation. This coincides with the formation of dense VIC and ECM conglomerates under endothelial aggregates, an additional biomarker of pathogenesis. Further, we discover that fibrotic tissue compaction is correlated with but not necessary for lesion formation. Additionally, we identify RhoA activation in disease-treated samples. We demonstrate that RhoA inhibition through ROCK, but not Rac1 inhibition, prevents delamination of the endothelial monolayer, fibrotic remodeling, and emergence of calcific lesions. Together, this work establishes a new longitudinal live-imaging platform that identifies emergent cell and matrix biological signatures of CAVD onset and enables the evaluation of therapeutic interventions. Graphical Abstract O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=64 SRC="FIGDIR/small/660489v1_ufig1.gif" ALT="Figure 1"> View larger version (24K): org.highwire.dtl.DTLVardef@dc378org.highwire.dtl.DTLVardef@19c37d5org.highwire.dtl.DTLVardef@11581c6org.highwire.dtl.DTLVardef@fb0a6a_HPS_FORMAT_FIGEXP M_FIG C_FIG
- organism: human
- assay: imaging
- research focus: cell type annotation
- research focus: differential expression
- research focus: cell-cell communication
- approach: microscopy & imaging analysis
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- VASP Promotes Aortic Valve Calcification by Interacting with FBLIM1 to Activate the Focal Adhesion Pathway
Xiaolin Liu, Qingyuan Xu, … Zhengjun Wang·bioRxiv·Jul 21, 2026
- Stromal CTHRC1 protects the valvular interstitium from macrophage-associated inflammatory remodeling and calcification
Hiroshi Sakamoto, Tomohisa Sakaue, … Hironori Izutani·bioRxiv·Sep 25, 2026
- Patient-Derived Circulating Monocytes Promote Calcific Aortic Valve Disease Progression
Léa Di Maria, Hugues Boël, … Sylvain Fraineau·bioRxiv·May 4, 2026
- Pharmacological activation of mitophagy prevents calcific aortic valve disease by targeting dysregulated mitochondrial-to-nuclear communication
Dao Zhou, Hanyi Dai, … Xianbao Liu·bioRxiv·Nov 2, 2026
- Capturing Multi-Scale Dynamics of Aortic Valve Calcification With a Coupled Fluid Structure and Systems Biology Model
Michael Quan, Tianyou Xie, … Haoxiang Luo·bioRxiv·Mar 19, 2026
- Selective PPAR-α activation with pemafibrate attenuates macrophage-mediated progression of calcific aortic valve disease
Mandy E Turner, Yuto Nakamura, … Elena Rabkin Aikawa·bioRxiv·Dec 19, 2025